Vivoryon

Vivoryon Therapeutics is a biopharmaceutical company that develops drugs for the treatment of Alzheimer's and oncology diseases.

Business Model:

Revenue: $0

Employees: 51-500

Rankings

Detailed Vivoryon Information

Geographic Data

Vivoryon headquarters map

Address: Weinbergweg 22

City: Halle

State: saxony-anhalt

Zip: 06120

Country: DE

Financial Info

Stage:

post ipo equity

Raised Last:

$15M

Raised Total:

$71M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Vivoryon Therapeutics is a biopharmaceutical company that develops drugs for the treatment of Alzheimer's and oncology diseases.

Contact Phone:

Contact Email:

Vivoryon went public on 10/24/2014 on the Other

Listed Exchange:
Other

IPO Date:
10/24/2014

Ticker Symbol:
VVY

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2019 Post-IPO Equity 1 $9.2M Claus Christiansen
Claus Christiansen
3/2022 Post-IPO Equity $23.3M
4/2022 Private Placement $23.3M
10/2019 Private Placement $47.8M
11/2009 Series B $0 Andera Partners
BB Biotech Ventures
bmp Ventures
CFH Management GmbH
HBM Healthcare Investments AG
IBG Beteiligungsgesellschaft Sachsen-Anhalt
Life Sciences Partners
TVM Capital
Andera Partners
BB Biotech Ventures
bmp Ventures
CFH Management GmbH
HBM Healthcare Investments AG
IBG Beteiligungsgesellschaft Sachsen-Anhalt
Life Sciences Partners
TVM Capital
1/2012 Venture Round 7 $19.4M TVM Capital
IBG Beteiligungsgesellschaft Sachsen-Anhalt
HBM Healthcare Investments AG
EQT life science
Biogen Idec
BB Biotech Ventures
Andera Partners
TVM Capital
IBG Beteiligungsgesellschaft Sachsen-Anhalt
HBM Healthcare Investments AG
EQT life science
Biogen Idec
BB Biotech Ventures
Andera Partners
10/2019 Post-IPO Equity $47.7M
9/2022 Post-IPO Equity 2 $14.7M Dawn Biopharma
Claus Christiansen
Dawn Biopharma
Claus Christiansen
6/2007 Series A 1 $20.6M Ingenium Pharamceutical
Ingenium Pharamceutical
9/2022 Post-IPO Equity 2 $14.7M Claus Christiansen
Dawn Biopharma
Claus Christiansen
Dawn Biopharma
3/2022 Post-IPO Equity $23.3M
10/2019 Post-IPO Equity $47.7M
4/2019 Post-IPO Equity 1 $9.2M Claus Christiansen
Claus Christiansen
1/2012 Venture Round 7 $19.4M Biogen Idec
HBM Healthcare Investments AG
EQT life science
TVM Capital
Andera Partners
BB Biotech Ventures
IBG Beteiligungsgesellschaft Sachsen-Anhalt
Biogen Idec
HBM Healthcare Investments AG
EQT life science
TVM Capital
Andera Partners
BB Biotech Ventures
IBG Beteiligungsgesellschaft Sachsen-Anhalt
11/2009 Series B 8 $54M
Announced Date Name Price
6/2007 Ingenium Pharmaceuticals AG

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research